Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Care | Position statement

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER

Authors: Lucas H. P. Bernts, David E. J. Jones, Marleen M. Kaatee, Ansgar W. Lohse, Christoph Schramm, Ekkehard Sturm, Joost P. H. Drenth

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

The European Reference Network for rare liver diseases (ERN RARE-LIVER) is a Europe-wide network of paediatric and adult hepatologists from expert centres in close collaboration with patient advocates from the various disease-areas covered in our ERN. The ERN is focused on providing more equitable care across Europe and creates a network of both medical specialists and patient experts in rare liver disease. This position paper summarizes the achievements of the first year and plots the route for the near future for ERN RARE-LIVER, as discussed during a strategy meeting that took place 27 and 28 February 2018 in Nijmegen, the Netherlands. ERN RARE-LIVER has established itself as a group with experts, hospitals and patients. One of the tools to improve communication is the clinical patient management system (CPMS) that allows access to expert consultation by European physicians confronted with a patient with rare liver disease. ERN RARE-LIVER will function as the platform to improve healthcare by initiating registries, foster research efforts and coordinate development of clinical guidelines in Europe.
Appendix
Available only for authorised users
Literature
1.
go back to reference Evangelista T, Hedley V, Atalaia A, Johnson M, Lynn S, Le Cam Y, et al. The context for the thematic grouping of rare diseases to facilitate the establishment of European reference networks. Orphanet J Rare Dis. 2016;11:17.CrossRef Evangelista T, Hedley V, Atalaia A, Johnson M, Lynn S, Le Cam Y, et al. The context for the thematic grouping of rare diseases to facilitate the establishment of European reference networks. Orphanet J Rare Dis. 2016;11:17.CrossRef
2.
go back to reference Heon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12(1):137.CrossRef Heon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12(1):137.CrossRef
3.
go back to reference Jones DEJ, Sturm E, Lohse AW. Access to care in rare liver diseases: new challenges and new opportunities. J Hepatol. 2018;68(3):577–85.CrossRef Jones DEJ, Sturm E, Lohse AW. Access to care in rare liver diseases: new challenges and new opportunities. J Hepatol. 2018;68(3):577–85.CrossRef
4.
go back to reference Dignass A. UEG standards and guidelines: a UEG initiative to reduce health inequalities across Europe. United European Gastroenterol J. 2016;4(4):621–2.CrossRef Dignass A. UEG standards and guidelines: a UEG initiative to reduce health inequalities across Europe. United European Gastroenterol J. 2016;4(4):621–2.CrossRef
5.
go back to reference van Grinsven J, van Brunschot S, van Santvoort HC, Dutch Pancreatitis Study G. The value of a 24/7 online Nationwide multidisciplinary expert panel for acute necrotizing Pancreatitis. Gastroenterology. 2017;152(4):685–8 e6.CrossRef van Grinsven J, van Brunschot S, van Santvoort HC, Dutch Pancreatitis Study G. The value of a 24/7 online Nationwide multidisciplinary expert panel for acute necrotizing Pancreatitis. Gastroenterology. 2017;152(4):685–8 e6.CrossRef
6.
go back to reference Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53(1):191–8.CrossRef Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53(1):191–8.CrossRef
7.
go back to reference de Boer YS, Liberal R, Vergani D, Mieli-Vergani G. Real-world management of juvenile autoimmune liver disease. United European Gastroenterol J. 2018;6(7):1032–8.CrossRef de Boer YS, Liberal R, Vergani D, Mieli-Vergani G. Real-world management of juvenile autoimmune liver disease. United European Gastroenterol J. 2018;6(7):1032–8.CrossRef
8.
go back to reference Wobser H, Paur T, Schnoy E, Hartl J, Kirchner GI. Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort. United European Gastroenterol J. 2018;6(2):247–54.CrossRef Wobser H, Paur T, Schnoy E, Hartl J, Kirchner GI. Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort. United European Gastroenterol J. 2018;6(2):247–54.CrossRef
9.
go back to reference Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, et al. Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017;45(5):723–32.CrossRef Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, et al. Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017;45(5):723–32.CrossRef
10.
go back to reference Kivela L, Popp A, Arvola T, Huhtala H, Kaukinen K, Kurppa K. Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United European Gastroenterol J. 2018;6(7):1022–31.CrossRef Kivela L, Popp A, Arvola T, Huhtala H, Kaukinen K, Kurppa K. Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United European Gastroenterol J. 2018;6(7):1022–31.CrossRef
11.
go back to reference D'Agnolo HM, Kievit W, Andrade RJ, Karlsen TH, Wedemeyer H, Drenth JP. Creating an effective clinical registry for rare diseases. United European Gastroenterol J. 2016;4(3):333–8.CrossRef D'Agnolo HM, Kievit W, Andrade RJ, Karlsen TH, Wedemeyer H, Drenth JP. Creating an effective clinical registry for rare diseases. United European Gastroenterol J. 2016;4(3):333–8.CrossRef
12.
go back to reference Cornock M. General data protection regulation (GDPR) and implications for research. Maturitas. 2018. Cornock M. General data protection regulation (GDPR) and implications for research. Maturitas. 2018.
13.
go back to reference European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145–72.CrossRef European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145–72.CrossRef
14.
go back to reference Trauner M, Nevens F, Shiffman ML, Drenth JPH, Bowlus CL, Vargas V, et al. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. Lancet Gastroenterol Hepatol. 2019. Trauner M, Nevens F, Shiffman ML, Drenth JPH, Bowlus CL, Vargas V, et al. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. Lancet Gastroenterol Hepatol. 2019.
15.
go back to reference Lee JY, Danford CJ, Trivedi HD, Tapper EB, Patwardhan VR, Bonder A. Treatment of fatigue in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci. 2019. Lee JY, Danford CJ, Trivedi HD, Tapper EB, Patwardhan VR, Bonder A. Treatment of fatigue in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci. 2019.
Metadata
Title
Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER
Authors
Lucas H. P. Bernts
David E. J. Jones
Marleen M. Kaatee
Ansgar W. Lohse
Christoph Schramm
Ekkehard Sturm
Joost P. H. Drenth
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1152-z

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue